Vats Biotech is focused on developing and marketing affordable healthcare products.
Indian pharmaceutical market witnessed a growth at a CAGR of 5.64% during FY 2011-16. By 2020, India is likely to be among top three pharmaceutical market
by incremental growth and sixth largest market globally by absolute size. Interestingly, with this growth nearly 40% of IPM's market share is dominated by
the top five companies and rest by others.
With these growing opportunities Vats Biotech is continuously focusing on how we can grow. At Vats, We strive to lead the way by aggressive penetration in
all targeted markets through an accomplished business strategies over the coming years by a highly dedicated and skilled team members while maintaining a
high priority to affordable and quality health care products.